PE20081401A1 - Derivados de indol como antagonistas de receptores vasopresina - Google Patents
Derivados de indol como antagonistas de receptores vasopresinaInfo
- Publication number
- PE20081401A1 PE20081401A1 PE2007001813A PE2007001813A PE20081401A1 PE 20081401 A1 PE20081401 A1 PE 20081401A1 PE 2007001813 A PE2007001813 A PE 2007001813A PE 2007001813 A PE2007001813 A PE 2007001813A PE 20081401 A1 PE20081401 A1 PE 20081401A1
- Authority
- PE
- Peru
- Prior art keywords
- indol
- alkyl
- antagonists
- dihydro
- carbonyl
- Prior art date
Links
- 102000004136 Vasopressin Receptors Human genes 0.000 title abstract 2
- 108090000643 Vasopressin Receptors Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- -1 6-CHLORO-1H-INDOL-3-CARBONYL Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- XVTILWLVPDMCSO-UHFFFAOYSA-N 1h-indole;piperidine Chemical class C1CCNCC1.C1=CC=C2NC=CC2=C1 XVTILWLVPDMCSO-UHFFFAOYSA-N 0.000 abstract 1
- WQKHERPPDYPMNX-UHFFFAOYSA-N 6-chloro-3,4-dihydro-2h-naphthalen-1-one Chemical compound O=C1CCCC2=CC(Cl)=CC=C21 WQKHERPPDYPMNX-UHFFFAOYSA-N 0.000 abstract 1
- 206010007558 Cardiac failure chronic Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
REFERIDA A UN DERIVADO DE INDOL-PIPERIDINA DE FORMULA (I), DONDE X ES CH2 E Y ES C=O, O X ES O E Y ES C=O, O X-Y ES N=N; R1 ES H, ALQUILO C1-C12, HALOALQUILO C1-C6, ENTRE OTROS; R2 ES H, ALQUILO C1-C6, C(O)Rn; Rn ES ALQUILO C1-C6, HETEROCICLCOALQUILO DE 3 A 7 MIEMBROS, ENTRE OTROS; R3, R4, R5 Y R6 SON H, HALOGENO, ALQUILO C1-C6, ENTRE OTROS; R7, R8, R9 Y R10 SON H, HALOGENO, ALQUILO C1-C6, ALCOXI C1-C6, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-[1-(6-CLORO-1H-INDOL-3-CARBONIL)-PIPERIDIN-4-IL]-1,3-DIHIDRO-INDOL-2-ONA, 1-{1-[6-CLORO-1-(3,5-DIFLUOR-BENCIL)-1H-INDOL-3-CARBONIL]-PIPERIDIN-4-IL}-1,3-DIHIDRO-INDOL-2-ONA, 2-{6-CLORO-3-[4-(2-OXO-2,3-DIHIDRO-INDOL-1-IL)-PIPERIDINA-1-CARBONIL]-INDOL-1-IL}-N-METIL-ACETAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE LA VASOPRESINA V1a Y SON UTILES EN EL TRATAMIENTO DE FALLO CARDIACO CRONICO, HIPERTENSION, CIRROSIS HEPATICA, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06127307 | 2006-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081401A1 true PE20081401A1 (es) | 2008-10-24 |
Family
ID=39198190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001813A PE20081401A1 (es) | 2006-12-28 | 2007-12-14 | Derivados de indol como antagonistas de receptores vasopresina |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20080161315A1 (es) |
| EP (1) | EP2125785B1 (es) |
| JP (1) | JP2010514726A (es) |
| KR (1) | KR101134255B1 (es) |
| CN (1) | CN101583609A (es) |
| AR (1) | AR064546A1 (es) |
| AT (1) | ATE533760T1 (es) |
| AU (1) | AU2007341377B2 (es) |
| BR (1) | BRPI0720968A2 (es) |
| CA (1) | CA2674133A1 (es) |
| CL (1) | CL2007003831A1 (es) |
| ES (1) | ES2375520T3 (es) |
| MX (1) | MX2009006920A (es) |
| NO (1) | NO20092356L (es) |
| PE (1) | PE20081401A1 (es) |
| RU (1) | RU2009124111A (es) |
| TW (1) | TWI345468B (es) |
| WO (1) | WO2008080842A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010093578A1 (en) * | 2009-02-10 | 2010-08-19 | Glaxo Group Limited | Indolinyl-, benzofuranyl-, and benzothienyl- amides as modulators of chemokine receptors |
| KR102799902B1 (ko) * | 2015-11-06 | 2025-04-28 | 에프. 호프만-라 로슈 아게 | 인돌린-2-온 유도체 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686624A (en) * | 1992-01-30 | 1997-11-11 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| CA2166975C (en) * | 1993-07-16 | 2005-04-05 | Mark G. Bock | Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| JPH0920779A (ja) * | 1995-05-01 | 1997-01-21 | Japan Tobacco Inc | 縮合ヘテロ５員環アゼピン化合物類及びその医薬用途 |
| US20080188478A1 (en) * | 2005-04-26 | 2008-08-07 | Pfizer Inc. | Compounds Useful In Therapy |
| PL1912976T3 (pl) | 2005-07-21 | 2009-04-30 | Hoffmann La Roche | Pochodne indol-3-ilokarbonylopiperydynobenzoimidazolu jako antagoniści receptora V1a |
| KR101020351B1 (ko) | 2005-07-29 | 2011-03-08 | 에프. 호프만-라 로슈 아게 | 인돌-3-일-카본일-피페리딘 및 피페라진 유도체 |
| WO2008068184A1 (en) * | 2006-12-08 | 2008-06-12 | F. Hoffmann-La Roche Ag | Indoles which act as via receptor antagonists |
-
2007
- 2007-12-14 PE PE2007001813A patent/PE20081401A1/es not_active Application Discontinuation
- 2007-12-19 CA CA002674133A patent/CA2674133A1/en not_active Abandoned
- 2007-12-19 BR BRPI0720968-1A patent/BRPI0720968A2/pt not_active IP Right Cessation
- 2007-12-19 US US11/959,522 patent/US20080161315A1/en not_active Abandoned
- 2007-12-19 JP JP2009543442A patent/JP2010514726A/ja active Pending
- 2007-12-19 EP EP07857799A patent/EP2125785B1/en not_active Not-in-force
- 2007-12-19 AT AT07857799T patent/ATE533760T1/de active
- 2007-12-19 WO PCT/EP2007/064176 patent/WO2008080842A1/en not_active Ceased
- 2007-12-19 MX MX2009006920A patent/MX2009006920A/es active IP Right Grant
- 2007-12-19 RU RU2009124111/04A patent/RU2009124111A/ru unknown
- 2007-12-19 AU AU2007341377A patent/AU2007341377B2/en not_active Ceased
- 2007-12-19 ES ES07857799T patent/ES2375520T3/es active Active
- 2007-12-19 US US11/959,545 patent/US8143281B2/en not_active Expired - Fee Related
- 2007-12-19 US US11/959,573 patent/US20080167344A1/en not_active Abandoned
- 2007-12-19 CN CNA2007800488386A patent/CN101583609A/zh active Pending
- 2007-12-19 KR KR1020097015736A patent/KR101134255B1/ko not_active Expired - Fee Related
- 2007-12-25 TW TW096150006A patent/TWI345468B/zh not_active IP Right Cessation
- 2007-12-27 AR ARP070105914A patent/AR064546A1/es not_active Application Discontinuation
- 2007-12-27 CL CL200703831A patent/CL2007003831A1/es unknown
-
2009
- 2009-06-19 NO NO20092356A patent/NO20092356L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2375520T3 (es) | 2012-03-01 |
| KR20090094395A (ko) | 2009-09-04 |
| TW200835491A (en) | 2008-09-01 |
| NO20092356L (no) | 2009-06-30 |
| EP2125785A1 (en) | 2009-12-02 |
| CA2674133A1 (en) | 2008-07-10 |
| AU2007341377B2 (en) | 2012-03-22 |
| WO2008080842A1 (en) | 2008-07-10 |
| KR101134255B1 (ko) | 2012-04-12 |
| US8143281B2 (en) | 2012-03-27 |
| BRPI0720968A2 (pt) | 2014-03-11 |
| TWI345468B (en) | 2011-07-21 |
| CN101583609A (zh) | 2009-11-18 |
| AR064546A1 (es) | 2009-04-08 |
| US20080167344A1 (en) | 2008-07-10 |
| MX2009006920A (es) | 2009-07-06 |
| US20080161315A1 (en) | 2008-07-03 |
| EP2125785B1 (en) | 2011-11-16 |
| JP2010514726A (ja) | 2010-05-06 |
| ATE533760T1 (de) | 2011-12-15 |
| AU2007341377A1 (en) | 2008-07-10 |
| RU2009124111A (ru) | 2011-02-10 |
| CL2007003831A1 (es) | 2008-07-11 |
| US20080161316A1 (en) | 2008-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091090A1 (es) | Derivados de piperidina como agonistas de receptores muscarinicos | |
| PE20080007A1 (es) | Compuestos derivados de bencimidazolona que tienen actividad en el receptor m1 | |
| PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
| PE20091173A1 (es) | Derivados de heteroarilo como antagonistas de receptor de orexina | |
| PE20090546A1 (es) | Derivados de imidazol como antagonistas de los receptores de quimioquina ccr-2, ccr-3 y ccr-5 | |
| PE20071152A1 (es) | Compuestos derivados de azabiciclo[3.1.0]hex como moduladores de receptores de dopamina d3 | |
| PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
| PE20081315A1 (es) | Derivados de benzimidazol como antagonistas de vr-1 | |
| PE20080344A1 (es) | Compuestos 8-azabiciclo[3.2.1]oct-8-il-1,2,3,4-tetrahidroquinolina sustituidos como inhibidores 11b-hsd1 | |
| PE20110574A1 (es) | Derivados de fenilamida y de piridilamida como agonistas de gpbar1 | |
| PE20090592A1 (es) | Nuevos derivados de piperazina-amida | |
| PE20090437A1 (es) | Antagonistas no basicos del receptor de la hormona concentradora de melanina 1 y procedimientos | |
| PE20050874A1 (es) | Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4 | |
| PE20120578A1 (es) | Agonistas y antagonistas del receptor de s1p5, y metodos de uso de los mismos | |
| PE20060625A1 (es) | Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina | |
| PE20090482A1 (es) | Derivados heterociclicos como antagonistas del receptor ccr2 | |
| PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
| PE20080056A1 (es) | Derivados de cromencarboxamida como antagonistas del receptor s1p1 | |
| PE20081851A1 (es) | Derivados de espiropiperidina-glicinamida | |
| PE20051173A1 (es) | Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3 | |
| PE20090622A1 (es) | Nuevos derivados de bencimidazol sustituido | |
| PE20091433A1 (es) | Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procedimientos para su preparacion 177 | |
| PE20081665A1 (es) | Antagonistas del receptor de dopamina 2 de rapida disociacion | |
| PE20081735A1 (es) | Derivados de 1-oxa-3[4,5]decan-2-ona en el tratamiento de trastornos alimenticios | |
| PE20070586A1 (es) | Compuestos de (4-piperidinil)-1,3-dihidro-2h-bencimidazol-2-ona sustituidos como agonistas del receptor muscarinico m1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |